Clinical Trial Update: A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing capecitabine with docetaxel versus capecitabine followed by docetaxel as first-line therapy for metastatic breast cancer was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 4 | Status: TERMINATED